Rights and permissions
About this article
Cite this article
Preliminary imatinib decision comes under fire in the UK. Inpharma Wkly. 1439, 3 (2004). https://doi.org/10.2165/00128413-200414390-00005
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-200414390-00005